EcoDrugPlus

Sterol O-Acyltransferase 1

Ensembl ID : ENSBTAG00000004059
Gene Symbol: SOAT1
4 Enzyme and pathways 5 Cross references
223 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSBTAG00000006975
Gene Symbol: SI
3 Enzyme and pathways 5 Cross references
213 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSBTAG00000024957
Gene Symbol: SNCA
5 Cross references
201 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSBTAG00000015575
Gene Symbol: TACR1
12 Enzyme and pathways 5 Cross references
283 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSBTAG00000021664
Gene Symbol: TACR2
8 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSBTAG00000016247
Gene Symbol: TACR3
8 Enzyme and pathways 5 Cross references
270 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSBTAG00000012567
Gene Symbol: TERT
9 Enzyme and pathways 5 Cross references
200 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSBTAG00000020225
Gene Symbol: TBXAS1
9 Enzyme and pathways 5 Cross references
231 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSBTAG00000014944
Gene Symbol: TBXA2R
13 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSBTAG00000007003
Gene Symbol: TYMS
3 Enzyme and pathways 5 Cross references
235 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSBTAG00000017802
Gene Symbol: THRB
9 Enzyme and pathways 5 Cross references
405 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSBTAG00000019997
Gene Symbol: TRHR
7 Enzyme and pathways 5 Cross references
281 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).